Pointe Capital Management LLC Eli Lilly & CO Transaction History

Pointe Capital Management LLC

$168 Million
Q3 2024

A detailed history of Pointe Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pointe Capital Management LLC holds 1,217 shares of LLY stock, worth $953,117. This represents 0.64% of its overall portfolio holdings.

Number of Shares

1,217

Previous 1,233 1.3%

Holding current value

$953,117

Previous $1.12 Million 3.41%

% of portfolio

0.64%

Previous 0.7%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$772.14 - $960.02 $12,354 - $15,360	-16 Reduced 1.3%	1,217 $1.08 Million
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $50,740 - $63,632	-70 Reduced 5.37%	1,233 $1.12 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $32,571 - $43,575	-55 Reduced 4.05%	1,303 $1.01 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $34,137 - $40,243	-65 Reduced 4.57%	1,358 $791,000
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $13,041 - $17,979	-30 Reduced 2.06%	1,423 $764,000
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $132,328 - $155,413	-426 Reduced 22.67%	1,453 $498,000
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $40,193 - $46,833	-125 Reduced 6.24%	1,879 $687,000
Q2 2022 Aug 26, 2022	SELL	$278.73 - $327.27 $27,873 - $32,727	-100 Reduced 4.75%	2,004 $650,000
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $23,384 - $29,020	-104 Reduced 4.71%	2,104 $581,000
Q1 2021 May 11, 2021	BUY	$164.32 - $212.72 $8,380 - $10,848	51 Added 2.36%	2,208 $412,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $62,881 - $83,207	-482 Reduced 18.26%	2,157 $364,000
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $10,777 - $12,970	-79 Reduced 2.91%	2,639 $433,000
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $177,912 - $193,522	-1,666 Reduced 38.0%	2,718 $304,000
Q2 2019 Aug 08, 2019	BUY	$110.79 - $129.32 $1,218 - $1,422	11 Added 0.25%	4,384 $486,000
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $6,789 - $7,992	61 Added 1.41%	4,373 $567,000
Q4 2018 Feb 06, 2019	SELL	$105.9 - $118.64 $131,845 - $147,706	-1,245 Reduced 22.4%	4,312 $499,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $28,848 - $36,056	336 Added 6.44%	5,557 $596,000
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $42,013 - $48,218	-555 Reduced 9.61%	5,221 $446,000
Q1 2018 May 10, 2018	BUY	$74.21 - $87.6 $4,081 - $4,818	55 Added 0.96%	5,776 $447,000
Q4 2017 Jan 12, 2018	SELL	$81.94 - $87.89 $15,978 - $17,138	-195 Reduced 3.3%	5,721 $483,000
Q3 2017 Oct 16, 2017	BUY	$77.07 - $85.54 $455,946 - $506,054	5,916	5,916 $506,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pointe Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pointe Capital Management LLC with notifications on news.

Account

Pointe Capital Management LLC Eli Lilly & CO Transaction History